Hepatitis Monthly

Published by: Kowsar

The Prevalence of Hepatitis A Among Blood Donors in Golestan Province in the Northeast of Iran

Shahla Shiukhi 1 , Ameneh Elikaei 1 , * and Zohreh Sharifi 2 , **
Authors Information
1 Department of Microbiology, Faculty of Biological Sciences, Alzahra University, Iran
2 Department of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iran
Corresponding Authors:
Article information
  • Hepatitis Monthly: November 2018, 18 (11); e81609
  • Published Online: November 13, 2018
  • Article Type: Research Article
  • Received: July 2, 2018
  • Revised: September 23, 2018
  • Accepted: October 19, 2018
  • DOI: 10.5812/hepatmon.81609

To Cite: Shiukhi S, Elikaei A, Sharifi Z. The Prevalence of Hepatitis A Among Blood Donors in Golestan Province in the Northeast of Iran, Hepat Mon. 2018 ; 18(11):e81609. doi: 10.5812/hepatmon.81609.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006;28:101-11. doi: 10.1093/epirev/mxj012. [PubMed: 16775039].
  • 2. Elikaei A, Sharifi Z, Shooshtari MM, Hosseini M, Maroufi Y. Prevalence of HAV among healthy blood donors referring to Tehran transfusion center. Iran J Pub Health. 2008;37(4):126-30.
  • 3. Yong HT, Son R. Hepatitis A virus: A general overview. Int Food Res J. 2009;16:455-67.
  • 4. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore. 1980;9(2):144-8. [PubMed: 7425524].
  • 5. Pourshams A, Saadatian-Elahi M, Nouraie M, Malekshah AF, Rakhshani N, Salahi R, et al. Golestan cohort study of oesophageal cancer: Feasibility and first results. Br J Cancer. 2005;92(1):176-81. doi: 10.1038/sj.bjc.6602249. [PubMed: 15597107]. [PubMed Central: PMC2361742].
  • 6. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005;34(3):600-9. doi: 10.1093/ije/dyi062. [PubMed: 15831565].
  • 7. Koff RS. Hepatitis A. Lancet. 1998;351(9116):1643-9. doi: 10.1016/s0140-6736(98)01304-x.
  • 8. da Silva SG, Leon LA, Alves G, Brito SM, Sandes Vde S, Lima MM, et al. A rare case of transfusion transmission of hepatitis A virus to two patients with haematological disease. Transfus Med Hemother. 2016;43(2):137-41. doi: 10.1159/000441910. [PubMed: 27226795]. [PubMed Central: PMC4872048].
  • 9. Cochran WG. Sampling techniques. 3rd ed. New York: Wiley India Pvt. Limited; 1977.
  • 10. Brundage SC, Fitzpatrick AN. Hepatitis A. Am Fam Physician. 2006;73(12):2162-8. [PubMed: 16848078].
  • 11. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: A global review and analysis. Epidemiol Infect. 2004;132(6):1005-22. doi: 10.1017/S0950268804002857. [PubMed: 15635957]. [PubMed Central: PMC2870191].
  • 12. Alavi Moghaddam M. Hepatitis A virus: A major global public health problem, especially in developing countries. Hepat Mon. 2005;5(4):145-9.
  • 13. Malekzadeh R, Khatibian M, Rezvan H. [Viral hepatitis in Iran and the world: Epidemiology, diagnosis, treatment, and prevention]. J Med Council Iran. 1997;15:183-200. Persian.
  • 14. Ramezani H, Bozorgi SH, Nooranipour M, Mostajeri A, Kargar-Fard H, Molaverdikhani S, et al. Prevalence and risk factors of hepatitis A among blood donors in Qazvin, central Iran. Singapore Med J. 2011;52(2):107-12. [PubMed: 21373737].
  • 15. Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Najafi-Tireh Shabankareh A, Sharifi Olyaie R, et al. Hepatitis A virus and hepatitis E virus seroprevalence among blood donors in Tehran, Iran. Hepat Mon. 2016;16(1). e32215. doi: 10.5812/hepatmon.32215. [PubMed: 27110256]. [PubMed Central: PMC4834187].
  • 16. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004;19(3):275-8. doi: 10.1023/B:EJEP.0000020345.37091.cd. [PubMed: 15117123].
  • 17. Atabek ME, Fyndyk D, Gulyuz A, Erkul I. Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey. Health Policy. 2004;67(3):265-9. doi: 10.1016/S0168-8510(03)00123-4. [PubMed: 15036814].
  • 18. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: A population based study. Arch Iran Med. 2010;13(2):99-104. [PubMed: 20187662].
  • 19. Yassin K, Awad R, Tebi A, Queder A, Laaser U. The epidemiology of hepatitis A infection in Palestine: A universal vaccination programme is not yet needed. Epidemiol Infect. 2001;127(2):335-9. doi: 10.1017/S0950268801005970. [PubMed: 11693511]. [PubMed Central: PMC2869753].
  • 20. Antaki N, Kebbewar MK. Hepatitis A seroprevalence rate in Syria. Trop Doct. 2000;30(2):99-101. doi: 10.1177/004947550003000215. [PubMed: 10842558].
  • 21. Meky FA, Stoszek SK, Abdel-Hamid M, Selim S, Abdel-Wahab A, Mikhail N, et al. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin Infect Dis. 2006;42(5):628-33. doi: 10.1086/500133. [PubMed: 16447107].
  • 22. Sun P, Su N, Lin FZ, Ma L, Wang HJ, Rong X, et al. Prevalence of hepatitis A viral RNA and antibodies among Chinese blood donors. Genet Mol Res. 2015;14(4):16431-7. doi: 10.4238/2015.December.9.13. [PubMed: 26662440].
  • 23. Crofts N, Cooper G, Stewart T, Kiely P, Coghlan P, Hearne P, et al. Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria. J Viral Hepat. 1997;4(5):333-8. doi: 10.1046/j.1365-2893.1997.00059.x. [PubMed: 9310932].
  • 24. Bouskraoui M, Bourrous M, Amine M. [Prevalence of anti-hepatitis A virus antibodies in chidren in Marrakech]. Arch Pediatr. 2009;16 Suppl 2:S132-6. French. doi: 10.1016/S0929-693X(09)75317-5. [PubMed: 19836677].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments